Sweet artificial intelligence as digital catalysts in infectious diseases: Glycomics and glycoanalysis
Biosensors and Bioelectronics · 2026-10 · 310 · 118863
DOI: 10.1016/j.bios.2026.118863 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors and Bioelectronics, 2026-10. Verfasst von Yuan Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China. Hauptthemen laut MEDLINE: Artificial Intelligence, Biosensing Techniques, Communicable Diseases, Glycomics. Die Arbeit nennt 234 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Glycans mediate microbial adhesion, host-cell entry, immune recognition and immune evasion, but their branching topology, linkage isomerism and context-dependent functions make glycan-centered infectious-disease research difficult to standardize. This review summarizes how artificial intelligence (AI), machine learning (ML) and deep learning (DL) are being applied to glycomics and glycoanalysis in infection biology. We first outline major sample sources, analytical platforms and curated databases used to generate glycan data, including mass spectrometry (MS), nuclear magnetic resonance (NMR), chromatography and glycan/lectin microarrays. We then compare supervised learning, unsupervised learning, graph neural networks(GNNs), sequence models and transformer-informed frameworks for glycan structure analysis, lectin-glycan binding prediction, pathogenicity assessment and biomarker discovery. Representative validated models, including SweetNet and LectinOracle, demonstrate that glycan-aware AI can achieve reproducible predictive performance across independent datasets. Finally, we discuss diagnostic applications, virulence forecasting, vaccine and drug development, and pathogen-related autoimmunity. Current limitations include sparse annotations, batch effects, incomplete structural coverage and limited model interpretability. Standardized datasets and interpretable multi-omics models will be essential for translating AI-driven glycoanalysis into pathogen surveillance and precision immunotherapy. In conclusion, this review summarizes how artificial intelligence (AI), machine learning (ML) and deep learning (DL) are being applied to glycomics and glycoanalysis in infection biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China.
- Department of Laboratory Medicine and Pathology, Foshan Fosun Chancheng Hospital, Foshan, Guangdong, 528000, China.
- Belmont Hill School, 350 Prospect St, Belmont, MA, 02478, United States.
- Department of Electrical and Computer Engineering, Worcester Polytechnic Institute, 100 Institute Road, MA, 01609, United States.
- Department of Computer Science, Worcester Polytechnic Institute, 100 Institute Road, MA, 01609, United States.
- School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China. Electronic address: zhouqin@hrbmu.edu.cn.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Gao, Y., Liu, J., Gong, B., Pei, J., Zhuang, X., Zeng, C., Zhang, H., Agu, E., Wang, Y., Duan, Z., Xue, K., Zhou, Q., & Cui, F. (2026). Sweet artificial intelligence as digital catalysts in infectious diseases: Glycomics and glycoanalysis. Biosensors and Bioelectronics, 310, 118863. https://doi.org/10.1016/j.bios.2026.118863
Vancouver
Gao Y, Liu J, Gong B, Pei J, Zhuang X, Zeng C, et al. Sweet artificial intelligence as digital catalysts in infectious diseases: Glycomics and glycoanalysis. Biosensors and Bioelectronics. 2026;310:118863. doi:10.1016/j.bios.2026.118863
BibTeX
@article{Gao2026,
author = {Gao, Yuan and Liu, Jianlei and Gong, Benjamin and Pei, Jianyuan and Zhuang, Xiwei and Zeng, Chijia and Zhang, Hangrui and Agu, Emmanuel and Wang, Yanling and Duan, Zhihao and Xue, Kunyang and Zhou, Qin and Cui, Feiyun},
title = {Sweet artificial intelligence as digital catalysts in infectious diseases: Glycomics and glycoanalysis},
journal = {Biosensors and Bioelectronics},
year = {2026},
volume = {310},
pages = {118863},
doi = {10.1016/j.bios.2026.118863}
}
EUVIMED